BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20606160)

  • 1. Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.
    Ding W; Knox TR; Tschumper RC; Wu W; Schwager SM; Boysen JC; Jelinek DF; Kay NE
    Blood; 2010 Oct; 116(16):2984-93. PubMed ID: 20606160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
    Ghosh AK; Secreto CR; Knox TR; Ding W; Mukhopadhyay D; Kay NE
    Blood; 2010 Mar; 115(9):1755-64. PubMed ID: 20018914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.
    Gehrke I; Gandhirajan RK; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
    Mol Med; 2011; 17(7-8):619-27. PubMed ID: 21519633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident Cardiac Atrial appendage Stem Cells.
    Windmolders S; De Boeck A; Koninckx R; Daniëls A; De Wever O; Bracke M; Hendrikx M; Hensen K; Rummens JL
    J Mol Cell Cardiol; 2014 Jan; 66():177-88. PubMed ID: 24326234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor over-expressed mesenchymal stem cells-conditioned media ameliorate palmitate-induced diabetic endothelial dysfunction through PI-3K/AKT/m-TOR/eNOS and p38/MAPK signaling pathway.
    Xu T; Lv Z; Chen Q; Guo M; Wang X; Huang F
    Biomed Pharmacother; 2018 Oct; 106():491-498. PubMed ID: 29990837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.
    Tabe Y; Jin L; Tsutsumi-Ishii Y; Xu Y; McQueen T; Priebe W; Mills GB; Ohsaka A; Nagaoka I; Andreeff M; Konopleva M
    Cancer Res; 2007 Jan; 67(2):684-94. PubMed ID: 17234779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments.
    Peng Y; Huang S; Wu Y; Cheng B; Nie X; Liu H; Ma K; Zhou J; Gao D; Feng C; Yang S; Fu X
    Stem Cells Dev; 2013 Dec; 22(24):3236-51. PubMed ID: 23885779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
    Crompot E; Van Damme M; Pieters K; Vermeersch M; Perez-Morga D; Mineur P; Maerevoet M; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
    Haematologica; 2017 Sep; 102(9):1594-1604. PubMed ID: 28596280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial progenitor cells promote viability and nerve regenerative ability of mesenchymal stem cells through PDGF-BB/PDGFR-β signaling.
    Fang J; Huang X; Han X; Zheng Z; Hu C; Chen T; Yang X; Ouyang X; Chen Z; Wei H
    Aging (Albany NY); 2020 Jan; 12(1):106-121. PubMed ID: 31899688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival.
    Trimarco V; Ave E; Facco M; Chiodin G; Frezzato F; Martini V; Gattazzo C; Lessi F; Giorgi CA; Visentin A; Castelli M; Severin F; Zambello R; Piazza F; Semenzato G; Trentin L
    Oncotarget; 2015 Dec; 6(39):42130-49. PubMed ID: 26517523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal.
    Gharibi B; Ghuman MS; Hughes FJ
    J Cell Mol Med; 2012 Nov; 16(11):2789-801. PubMed ID: 22805337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells.
    Ball SG; Bayley C; Shuttleworth CA; Kielty CM
    Biochem J; 2010 Mar; 427(1):29-40. PubMed ID: 20102335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components.
    Fekete N; Gadelorge M; Fürst D; Maurer C; Dausend J; Fleury-Cappellesso S; Mailänder V; Lotfi R; Ignatius A; Sensebé L; Bourin P; Schrezenmeier H; Rojewski MT
    Cytotherapy; 2012 May; 14(5):540-54. PubMed ID: 22296115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy.
    Fierro FA; Kalomoiris S; Sondergaard CS; Nolta JA
    Stem Cells; 2011 Nov; 29(11):1727-37. PubMed ID: 21898687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration on the expression of IL-1, PDGF, TGF-beta, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients.
    Hofer EL; La Russa V; Honegger AE; Bullorsky EO; Bordenave RH; Chasseing NA
    Stem Cells Dev; 2005 Oct; 14(5):587-94. PubMed ID: 16305343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration.
    Sassoli C; Vallone L; Tani A; Chellini F; Nosi D; Zecchi-Orlandini S
    Cell Tissue Res; 2018 Jun; 372(3):549-570. PubMed ID: 29404727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia.
    Shehata M; Schnabl S; Demirtas D; Hilgarth M; Hubmann R; Ponath E; Badrnya S; Lehner C; Hoelbl A; Duechler M; Gaiger A; Zielinski C; Schwarzmeier JD; Jaeger U
    Blood; 2010 Oct; 116(14):2513-21. PubMed ID: 20576813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor-BB enhances MSC-mediated cardioprotection via suppression of miR-320 expression.
    Xu B; Luo Y; Liu Y; Li BY; Wang Y
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H980-9. PubMed ID: 25724494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.
    Ding W; Nowakowski GS; Knox TR; Boysen JC; Maas ML; Schwager SM; Wu W; Wellik LE; Dietz AB; Ghosh AK; Secreto CR; Medina KL; Shanafelt TD; Zent CS; Call TG; Kay NE
    Br J Haematol; 2009 Nov; 147(4):471-83. PubMed ID: 19751240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.